Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Clinical trial NCT03938246 · COMPLETED

Trial details

NCT number: NCT03938246
Sponsor: Sagimet Biosciences Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)

Start date: 2019-03-22
Primary completion: 2021-10-02
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.